In the News

The US Food and Drug Administration (FDA) approved burosumab-twza (Crysvita) injection to treat patients aged 2 years and older with tumour-induced osteomalacia (TIO).

“Treatment for TIO focuses on identifying and removing the tumour that causes the disease; however, when that is not...

The US Food and Drug Administration (FDA) has approved canakinumab (Ilaris) injection for the treatment of active Still’s Disease, including adult-onset Still’s Disease (AOSD).

“Prior to today’s approval, patients had no FDA-approved treatments for their disease, which can include...

The American College of Rheumatology (ACR) has published new guidelines for the management of gout.

The updated guideline, published in Arthritis Care & Research, reflects new clinical evidence that became available since the ACR last released a treatment guideline for the...

Autoimmunity appears to be increasing in the United States, according to a study published in Arthritis and Rheumatology.

Frederick Miller, MD, National Institute of Environmental Health Sciences (NIEHS), part of the National Institutes of Health, Bethesda, Maryland, and colleagues...

Use of low-dose methotrexate is associated with small to moderate elevations in risks for skin cancer and gastrointestinal, infectious, pulmonary, and haematologic adverse events, according to a study published in the Annals of Internal Medicine.

Methotrexate is the most commonly...

Amlodipine lowered long-term gout risk, compared with lisinopril or chlorthalidone, in older adults with hypertension, according to a study published in the Journal of Hypertension.

“Our study is clinically relevant as the prevalence of gout has been rising in the United States and...

Researchers have identified the cause of a mysterious illness that has affected 3 families over the past 20 years, and have termed the new disease Cleavage-Resistant RIPK1-Induced Autoinflammatory (CRIA) Syndrome.

Daniel Kastner, MD, National Human Genome Research Institute (NHGRI), part...

Heart disease is an independent risk factor for severe adverse skin reactions in patients taking allopurinol for gout, according to a study published in CMAJ.

A previous study found an association between heart disease and increased risk of hospitalisation for allopurinol-related...

The US Food and Drug Administration (FDA) has approved rituximab (Rituxan) injection to treat granulomatosis with polyangiitis (GPA) and microscopic polyangiitis (MPA) in children aged ≥2 years in combination with glucocorticoids.

This is the first approved treatment for children with...

Four modifiable risk factors could individually account for a notable proportion of hyperuricemia cases, according to a study published in Arthritis & Rheumatology.

For the study, Hyon K. Choi, MD, Massachusetts General Hospital, Boston, Massachusetts, and colleagues used data...

Pages